Latest News from ASCO in Action

Latest News from ASCO in Action

July 7, 2015

CMS has released its proposed rule for the Hospital Outpatient Prospective Payment System for 2016. Typically, this rule is released along with the Physician Fee Schedule Rule.  ASCO will post a notification as soon as the rule for physicians is released. 

July 7, 2015

Kevin Fitzpatrick has been named Chief Executive Officer (CEO) of CancerLinQ LLC, a wholly owned non-profit subsidiary of ASCO. Mr. Fitzpatrick, who is currently the Executive Vice President and Chief Innovation Officer of the American College of Cardiology (ACC), will begin his new role on August 3.

July 2, 2015

ASCO has sent letters to the lead sponsors of U.S. House and Senate in support of legislation that would require private health insurance plans offering intravenous cancer drug benefits to provide parity for orally administered and self-injectable cancer drugs.

H.R. 2739 and S. 1566, the Cancer Drug Coverage Parity Act, were respectively introduced by Representatives Leonard Lance (R-NJ) and Brian Higgins (D-NY) and Senators Mark Kirk (R-IL) and Al Franken (D-MN).

ASCO's ACT Network

ASCO's ACT Network

ALERT CONGRESS TODAY! Use ASCO's ACT Network to contact your elected officials on important policy issues impacting cancer care. 

ASCO Issue Backgrounders

ASCO Issue Backgrounders

ASCO offers issue backgrounders to help provide an overview of the major policy issues that impact patients with cancer and the physicians who care for them. The issue backgrounders cover topics such as reimbursement, health equity, cancer research funding, and more.

Click here to read the backgrounds and help develop your understanding of cancer policy issues.

NIH Funding Educational Series

NIH Funding Educational Series

ASCO explores the decade-long decline in federal funding for cancer research – and why this decline must be reversed. Read more here.